Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Thorac Oncol. 2018 Dec 7;14(4):683–690. doi: 10.1016/j.jtho.2018.12.002

Figure 3.

Figure 3.

Duration of treatment. Arrows indicate patients continuing on alectinib at data cutoff. Triangles indicate the time points at which a CNS response was first observed. Circles represent the time points of CNS disease progression. Asterisk indicates a patient whose disease was unevaluable for CNS response.